Skip to main content
Publications
Pladevall-Vila M, Ziemiecki R Johannes CB Khan AM Layton JB Clinical profile and treatment patterns in individuals with type 2 diabetes and chronic kidney disease who initiate a GLP-1 receptor agonist: a multinational cohort study
Craig T, Baptist AP, Anderson J, Zaragoza-Urdaz RH, Burnette AF, Kelbel TE, Riedl MA, Vanegas A, Boyle K Bartsch JL Darden C Brown TM Hereditary angioedema: patient health care experiences within underrepresented racial and ethnic groups in the United States 10.1016/j.anai.2025.01.007
Weisel K, Mateos MV, Landgren O, Leleu X, Quach H, Bennett L Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with carfilzomib, dexamethasone, and daratumumab versus carflizomib and dexamethasone: an analysis of patient-reported outcomes from the phase 3 CANDOR trial 10.1016/j.clml.2025.02.005
Hellwig K, Magyari M, MacDonald TM, Cesta CE, Wergeland S, Leinonen MK, Ornoy A, Vukusic S, Lauer A, Zhou X Kawai A Weinrib R Arana A A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update1
Wainberg ZA, Enzinger PC, Qin S, Yamaguchi K, Wang J Zhou X Gnanasakthy A Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer
Buck P, Sweeney C Boyle K Chirila C Crawford R Wolowacz S Family spillover impact of congenital CMV in the United States and Canada: study methodology
Ayoub I, Bensink ME, Zhou X Wang J Patient-reported outcomes in adults with FSGS: sparsentan vs. irbesartan
Wadhwani S, Bensink M, Peipert JD, Ayoub I, Preciado P, Garbinsky D Wang J Choi J Bennett L Patient-reported outcomes in the PROTECT clinical trial comparing sparsentan with irbesartan for IgA nephropathy
Haug U, Morales DR, Ehrenstein V, Esen BO, Didelez V, Schafer W, Reinbold J, Martinez D Garcia de Albeniz X Target trial emulation with real world evidence: regulatory grade pharmacoepidemiology in the SIGMA consortium
Weibel D, De Luise C, Cid Royo A, Ryan O, Vaz T, Aguado J Marsal J Garcia de Albeniz Martinez X Weinrib R Arana A Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Taieb J, Fakih M, Salvatore L, Esaki T, Modest DP, Paez D, Karamouzis MV, Ruiz-Garcia E, Kim TW, Kuboki Y, Meriggi F, Cunningham D, Yeh KH, Cremolini C, Wang J Patient-reported tolerability of sotorasib (soto) and panitumumab (pani) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in patients (pts) with metastatic colorectal cancer (mCRC) in the CodeBreaK 300 study
Kluge F, Brand YE, Mico-Amigo ME, Bertuletti S, D'Ascanio I, Gazit E, Bonci T, Kirk C, Kuderle A, Palmerini L, Paraschiv-Ionescu A, Salis F, Soltani A, Ullrich M, Alcock L, Aminian K, Becker C, Brown P, Buekers J, Carsin AE Real-world gait detection using a wrist-worn inertial sensor: validation study
Koch S, Peralta GP, Carsin AE Abellan A Physical activity and body mass related to catch-up lung function growth in childhood: a population-based accelerated cohort study 10.1136/thorax-2022-219666
Craig T, Baptist A, Anderson J, Zaragoza-Urdaz R, Burnette A, Kelbel T, Riedl M, Vanegas A, Boyle K Patient-reported outcomes among patients with hereditary angioedema within underrepresented racial or ethnic groups
Law EH, Sherif B Korver D Chirila C Patients with alopecia areata treated with ritlecitinib have improved patient-reported emotional symptoms and activity limitations due to hair loss: post hoc analyses of ALLEGRO-2b/3
Carsin AE Spirometric patterns in young and middle-aged adults: a 20-year European study 10.1136/thorax-2022-219696
Gold BD, Goodwin B, Davis K, Sweeney C Reynolds M Health-related quality of life and perceived stigma in eosinophilic esophagitis: a real-world, US, web-based survey
Zografos LJ Wolin DL Calingaert B Davenport EK Evaluation of physician knowledge of safety and safe use information for intravitreal aflibercept injection in Europe: a second survey of physicians following dissemination of updated risk-minimization materials
Moehler M, Wyrwicz L, Chen C, Davenport E Wang J Health-related quality of life (HRQOL) in patients with advanced gastric, gastroesophageal junction, or esophageal adenocarcinoma cancer (GC/GEJC/EAC): 36-month results of CheckMate 649 nivolumab plus chemotherapy (N+C) vs (C)
Hamadani M, Spira AI, Zhou X Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial 10.1182/bloodadvances.2023010636
Moehler M, Xiao H, Blum SI, Elimova E, Cella D, Shitara K, Ajani JA, Janjigian YY, Garrido M, Shen L, Yamaguchi K, Liu T, Schenker M, Kowalyszyn R, Bragagnoli AC, Bruges R, Montesarchio V, Pazo-Cid R, Hunter S, Davenport E Wang J Health-Related quality of life with nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric/gastroesophageal junction cancer or esophageal adenocarcinoma from CheckMate 649
Kirkeleit J, Riise T, Wielscher M, Accordini S, Carsin AE Early life exposures contributing to accelerated lung function decline in adulthood - a follow-up study of 11,000 adults from the general population
